Charlotte Teneback, MD
Pulmonary Disease · Burlington, VTNPI 1427110782
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pulmonary disease clinicians in VT, where the typical reported total is $343.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
Across 46 payments — averaging $23,071 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Vertex$1.1M
- Boehringer Ingelheim International GmbH$4K
- Boehringer Ingelheim$4K
- Novartis$11
How this compares
$0 in reported general payments places this provider in the 30th percentile of 25 pulmonary disease providers in Vermont.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrikaftaElexacaftor/Tezacaftor/Ivacaft | 70 | $1,980,247 |
| OfevNintedanib Esylate | 13 | $188,100 |
| ZenpepLipase/Protease/Amylase | 17 | $160,155 |
| CreonLipase/Protease/Amylase | 22 | $121,752 |
| Dupixent PenDupilumab | 20 | $77,261 |
| Pirfenidone | 17 | $51,904 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $43,590 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 20 | $10,665 |
| Breo ElliptaFluticasone/Vilanterol | 19 | $10,516 |
| Incruse ElliptaUmeclidinium Bromide | 16 | $7,864 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $7,828 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $7,376 |
| Spiriva HandihalerTiotropium Bromide | 11 | $6,444 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $3,048 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 70 | $2,964 |
Paid to pharmacies, not to this prescriber.
Other pulmonary disease in Burlington
- Charles KinseyBurlington$34K
- Emily DucombBurlington$10K
- Anne DixonBurlington$4K
- Daniel WeissBurlington$3K
- Christopher YuroskoBurlington$2K
- Ena GuptaBurlington$2K
- Marta KokoszynskaBurlington$1K
- Suman MajumdarBurlington$786
- Jessica BadlamBurlington$642
- Prema MenonBurlington$18
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.